Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Randomized, Controlled Trial Evaluating GS-5806 in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection

NCT02534350 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02534350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02534350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Randomized, Controlled Trial Evaluating GS-5806 in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2015
Completion date
September 27, 2017
Enrollment
61 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus (rsv)